NSE
LINCOLN

Lincoln Pharmaceuticals Limited

Prices are adjusted according to historical splits.

Lincoln Pharmaceuticals Limited Stock Price

Vitals

Today's Low:
492.5
Today's High:
535.7
Open Price:
535
52W Low:
52W High:
Prev. Close:
533.55
Volume:
224140

Company Statistics

Market Cap.:
0
Book Value:
Revenue TTM:
0
Operating Margin TTM:
0%
Gross Profit TTM:
0
Profit Margin:
0%
Return on Assets TTM:
0%
Return on Equity TTM:
0%

Company Profile

Lincoln Pharmaceuticals Limited had its IPO on under the ticker symbol LINCOLN.

The company operates in the sector and industry. Lincoln Pharmaceuticals Limited has a staff strength of 0 employees.

Stock update

Shares of Lincoln Pharmaceuticals Limited opened at 535 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of 492.5 - 535.7, and closed at 498.75.

This is a -6.52% slip from the previous day's closing price.

A total volume of 224,140 shares were traded at the close of the day’s session.

In the last one week, shares of Lincoln Pharmaceuticals Limited have slipped by -3.71%.

Lincoln Pharmaceuticals Limited's Key Ratios

Lincoln Pharmaceuticals Limited has a market cap of 0, indicating a price to book ratio of and a price to sales ratio of .

In the last 12-months Lincoln Pharmaceuticals Limited’s revenue was 0 with a gross profit of 0 and an EBITDA of 0. The EBITDA ratio measures Lincoln Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Lincoln Pharmaceuticals Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q0.33333333333333, Lincoln Pharmaceuticals Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Lincoln Pharmaceuticals Limited’s PE and PEG Ratio

Forward PE
Trailing PE
PEG

Its diluted EPS in the last 12-months stands at per share while it has a forward price to earnings multiple of and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lincoln Pharmaceuticals Limited’s profitability.

Lincoln Pharmaceuticals Limited stock is trading at a EV to sales ratio of and a EV to EBITDA ratio of . Its price to sales ratio in the trailing 12-months stood at .

Lincoln Pharmaceuticals Limited stock pays annual dividends of per share, indicating a yield of and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
0
Total Liabilities
0
Operating Cash Flow
0
Capital Expenditure
0
Dividend Payout Ratio
0%

Lincoln Pharmaceuticals Limited ended 1970 with 0 in total assets and 0 in total liabilities. Its intangible assets were valued at 0 while shareholder equity stood at 0.

Lincoln Pharmaceuticals Limited ended 1970 with 0 in deferred long-term liabilities, 0 in other current liabilities, in common stock, 0 in retained earnings and 0 in goodwill. Its cash balance stood at 0 and cash and short-term investments were 0. The company’s total short-term debt was 0 while long-term debt stood at 0.

Lincoln Pharmaceuticals Limited’s total current assets stands at 0 while long-term investments were 0 and short-term investments were 0. Its net receivables were 0 compared to accounts payable of 0 and inventory worth 0.

In 1970, Lincoln Pharmaceuticals Limited's operating cash flow was 0 while its capital expenditure stood at 0.

Comparatively, Lincoln Pharmaceuticals Limited paid 0 in dividends in 1970.

Other key metrics

Current Trading Price
498.75
52-Week High
52-Week Low
Analyst Target Price

Lincoln Pharmaceuticals Limited stock is currently trading at 498.75 per share. It touched a 52-week high of and a 52-week low of . Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was 453.94 and 200-day moving average was 385.05 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Lincoln Pharmaceuticals Limited

The stock symbol (also called stock or share ticker) of Lincoln Pharmaceuticals Limited is LINCOLN

The IPO of Lincoln Pharmaceuticals Limited took place on

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
0.14
0.07
+100%
0.12
0.04
+45.29%
0.96
0.05
+5.4%
1.34
-0.35
-20.71%
Humbl Inc (HMBL)
0
0
0%

Top Gainers

Last Price
Chg
Chg%
0
0
+172200%
0
0
+51200%
283
280.03
+9428.62%
11.2
10.57
+1667.68%
Latch Inc (LTCHW)
0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
0.19
-123.15
-99.85%
0
-0.11
-99.55%
0
-0
-97.96%
0
-0.01
-93.94%
0.01
-0.06
-92.24%

About

Address